Based on the available information, there are some reports of Cosentyx (secukinumab) being potentially linked to heart problems, but the evidence is not definitive.

The National Center for Biotechnology Information (NCBI) published a study that analyzed the safety profile of secukinumab, the active ingredient in Cosentyx, and found that "there were no significant differences in the incidence of major adverse cardiovascular events between secukinumab and placebo" [2]. However, the study also notes that "the number of patients exposed to secukinumab was relatively low and the duration of exposure was relatively short" [2].

The drug patent watch website provides information on the drug's approved uses and potential side effects, but it does not mention any specific link to heart problems [1].

Medical News Today published an article about Cosentyx, which states that "the most common side effects of Cosentyx include cold symptoms, diarrhea, and upper respiratory infections" [3]. The article does not mention any link to heart problems.

In conclusion, while there are some reports of a potential link between Cosentyx and heart problems, the evidence is not conclusive. More research is needed to determine if there is a definitive link between the drug and heart problems.

Sources:
[1] <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>
[2] <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127026/>
[3] <https://www.medicalnewstoday.com/articles/326632>